Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global agrigenomics market was valued at USD 5.01 billion in 2024. The market is projected to grow to USD 7.92 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.9% during the forecast period.
Agrigenomics is the application of genomics, bioinformatics, and molecular tools to enhance agricultural productivity and sustainability. It encompasses a suite of products and scientific services for both crops and livestock, including DNA extraction and purification, DNA/RNA sequencing, genotyping, gene expression profiling, and marker-assisted selection. These technologies are fundamental for improving yield, developing disease resistance, and ensuring trait purity.
This market expansion is primarily driven by the urgent global need to bolster food security for a growing population. There is a significant surge in demand for high-yield and climate-resilient crops, which agrigenomic tools directly address. Key players such as Thermo Fisher Scientific, Illumina, and Agilent Technologies collectively command a dominant share of approximately 40% of the global market. Furthermore, North America is the largest regional market, accounting for roughly 50% of global revenue, because of its advanced technological infrastructure and significant R&D investments. The continuous technological advancements in sequencing platforms are a critical catalyst for this growth.
Demand for Enhanced Crop Productivity and Yield
The global pressure to increase food production for a growing population is a primary driver for the agrigenomics market. Advancements in genomic technologies enable the development of high-yielding, stress-resistant crop varieties, which is crucial for food security. The adoption of sequencing and molecular breeding techniques allows for more precise and accelerated crop improvement.
Rising Investment in Agricultural R&D
Substantial investments from both public and private sectors into agricultural research are fueling market growth. Governments and agribusiness corporations are allocating significant funds to genomic research to develop sustainable agricultural practices and improve livestock health. This financial backing is critical for the commercialization of new genomic tools and services.
➤ The integration of next-generation sequencing (NGS) and CRISPR gene-editing technologies is revolutionizing traditional breeding programs, significantly reducing the time required to develop new traits.
The declining cost of DNA sequencing is making genomic technologies more accessible to a broader range of users, from large agribusinesses to smaller research institutions. This cost reduction is democratizing access to powerful tools for genetic analysis, further propelling market expansion.
MARKET CHALLENGES
High Initial Capital Investment and Technical Expertise
The agrigenomics market faces significant hurdles related to the high cost of advanced genomic equipment, such as sequencers and bioinformatics software. Furthermore, the field requires a specialized workforce with expertise in genomics, bioinformatics, and data science, which can be scarce and expensive to recruit and retain.
Other Challenges
Data Management and Integration Complexity
The vast amount of data generated by genomic sequencing presents a major challenge in terms of storage, analysis, and interpretation. Integrating this complex genomic data with other agricultural data sets, such as field performance and environmental data, requires sophisticated bioinformatics infrastructure.
Regulatory and Public Acceptance Hurdles
Stringent government regulations governing genetically modified organisms (GMOs) and gene-edited products can delay the commercialization of new developments. Public skepticism and varying international regulatory frameworks also pose challenges for the global adoption of genomic technologies in agriculture.
Limited Awareness in Developing Regions
Despite the potential benefits, the adoption of advanced agrigenomics solutions remains limited in many developing regions. A lack of awareness about the long-term advantages, coupled with limited financial resources and infrastructure, restricts market penetration in these areas, slowing overall market growth.
Ethical and Socio-Economic Concerns
Ethical debates surrounding genetic modification and the potential socio-economic impact on smallholder farmers act as significant restraints. Concerns about biodiversity loss and the control of genetic resources by large corporations can lead to public opposition and stricter regulations.
Expansion into Livestock and Aquaculture Genomics
There is substantial growth potential in applying genomic technologies beyond crops to livestock and aquaculture. Genomic selection can improve animal health, productivity, and disease resistance, offering a significant opportunity for market expansion in the animal agriculture sector.
Advent of Personalized Agriculture and Microbiome Research
The emergence of personalized agriculture, which tailors farming practices based on the genetic makeup of specific crops or soils, presents a new frontier. Furthermore, research into the plant and soil microbiome offers opportunities to develop microbial solutions that enhance nutrient uptake and plant health, creating new revenue streams.
Growth in Precision Farming and Digital Agriculture
The integration of agrigenomics with precision farming tools and digital agriculture platforms is a key opportunity. Combining genetic data with real-time field data from sensors and drones can optimize resource use and maximize yields, driving demand for integrated solutions.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Illumina HiSeq is the dominant technology type, widely adopted due to its proven high-throughput capabilities, accuracy, and cost-effectiveness for large-scale genomic studies. Its extensive use in research and diagnostic applications provides a solid foundation for market leadership. Platforms like PacBio Sequencer are gaining significant traction for their long-read sequencing advantages, which are particularly valuable for resolving complex genomic regions and de novo assemblies, indicating a strong growth trajectory. The 'Others' category, encompassing various essential services like genotyping and gene expression profiling, represents a critical and diversified segment driven by the need for comprehensive analytical solutions beyond core sequencing. |
| By Application |
|
Crops is the leading application segment, fueled by the global imperative to enhance food security through the development of high-yielding, climate-resilient, and nutritionally enriched plant varieties. Marker-assisted selection and genomic tools are instrumental in accelerating breeding cycles. The Livestock application is also a major and rapidly evolving segment, where agrigenomics is crucial for improving animal health, increasing productivity, and ensuring the sustainability of meat and dairy production. The focus on breeding for disease resistance and superior genetic traits in livestock is a key driver for this segment's robust expansion. |
| By End User |
|
Academic & Research Institutes represent the foundational end-user segment, driving fundamental discoveries and methodological advancements in genomics. Their extensive R&D activities create a continuous demand for sequencing services and technologies. However, Biotechnology Companies and Seed & Livestock Manufacturers are increasingly dominant forces, leveraging agrigenomics for direct commercial application and product development. These commercial entities are the primary drivers of market innovation and adoption, as they integrate genomic data into their breeding programs to create proprietary, high-value seeds and animal genetics, thereby capturing significant market value. |
| By Service Offering |
|
Sequencing Services form the core service offering, representing the essential first step in genomic analysis and generating the raw data required for all downstream applications. The demand for high-quality, cost-effective sequencing is pervasive. Bioinformatics & Data Analysis is emerging as the most critical and value-adding segment, as the sheer volume and complexity of genomic data necessitate sophisticated computational tools for meaningful interpretation. The ability to transform sequence data into actionable insights for breeding and trait selection is becoming a key differentiator and a major area of investment and growth within the agrigenomics market landscape. |
| By Objective |
|
Yield & Productivity Enhancement is the predominant objective driving agrigenomics adoption, directly addressing the need to increase food production for a growing global population. This focus on maximizing output per unit of land or animal is a primary commercial driver. Disease & Pest Resistance is a critically important objective, as reducing crop losses and improving animal health through genetic means offers significant economic and sustainability benefits. There is also a growing emphasis on Nutritional Improvement, with genomics being used to develop biofortified crops that address micronutrient deficiencies, reflecting an evolving focus on food quality alongside quantity. |
A Market Characterized by Technological Dominance and Strategic Diversification
The global agrigenomics market is marked by a consolidated landscape where the top five players, namely Thermo Fisher Scientific, Illumina, Agilent Technologies, Eurofins, and Zoetis, collectively command approximately 40% of the market share. These leaders have established their dominance through a combination of technological expertise, extensive product portfolios, and significant investment in research and development. Thermo Fisher Scientific and Illumina, in particular, are pivotal due to their provision of high-throughput sequencing platforms and associated consumables, which are fundamental to genomic applications in agriculture. Their strategies often involve strategic acquisitions, partnerships with agricultural research institutions, and continuous innovation in sequencing technologies to maintain a competitive edge and cater to the growing demand for precision agriculture and sustainable food production solutions.
Beyond the market leaders, the landscape includes several other significant players who compete by specializing in niche applications or offering integrated services. Companies such as LGC Limited, BGI, and Neogen Corporation provide crucial services in areas like genotyping, genetic trait analysis, and food safety testing, serving specific segments of the crop and livestock markets. Pacific Biosciences offers advanced long-read sequencing technologies that are valuable for complex genome assemblies. Furthermore, specialized service providers and technology firms like NuGEN Technologies, Edico Genome, and CEN4GEN Institute focus on developing optimized sample preparation kits, bioinformatics solutions, and genomic services, addressing the need for data analysis and accessibility for a broader range of agricultural stakeholders. This diverse ecosystem of companies fosters innovation and drives the application of genomics across the agricultural value chain.
List of Key Agrigenomics Companies ProfiledThermo Fisher Scientific
Eurofins
Zoetis
LGC Limited
Pacific Biosciences
CEN4GEN Institute
NuGEN Technologies
Edico Genome
UD-GenoMed Limited
SciGenom
The global Agrigenomics market is experiencing robust expansion, driven by the critical need to enhance agricultural productivity for a growing global population. The market, valued at $5008 million in 2024, is projected to reach $7918 million by 2031, growing at a CAGR of 6.9%. This growth trajectory is underpinned by the increasing adoption of genomic technologies to develop high-yield, climate-resilient crops and healthier livestock. The field encompasses a range of scientific services, including DNA/RNA sequencing, genotyping, and marker-assisted selection, which are becoming integral to modern agricultural practices. North America remains the dominant regional market, accounting for approximately 50% of the global share, supported by strong R&D infrastructure and early technology adoption.
Other TrendsConsolidation and Leadership Among Key Players
The competitive landscape is characterized by the dominance of a few major players. Industry leaders including Thermo Fisher Scientific, Illumina, Agilent Technologies, Eurofins, and Zoetis collectively hold about 40% of the market share. This concentration reflects a trend of strategic mergers, acquisitions, and partnerships aimed at expanding technological portfolios and global reach. These companies are continuously investing in the development of advanced sequencing platforms like Illumina HiSeq and PacBio Sequencers, which are critical for applications in both crops and livestock. The high market share of these established players creates a high barrier to entry for new competitors.
Segmentation and Application-Specific Innovations
The market is segmented by technology type and application. In terms of technology, sequencers such as Illumina HiSeq, Sanger Sequencer, and PacBio Sequencer are key drivers. The application segment is divided between crops and livestock, with significant R&D focused on improving disease resistance, nutritional content, and yield efficiency in both areas. The push for sustainable agriculture and precision farming is accelerating the adoption of genotyping and gene expression profiling to enable marker-assisted selection, allowing breeders to make more informed and efficient decisions.
Expansion into Emerging Markets and Regional DiversificationWhile North America leads, significant growth potential exists in the Asia-Pacific and European regions. Governments and private entities in these areas are increasingly funding agrigenomics research to bolster food security. The market's expansion is also supported by declining costs of genetic sequencing, making these technologies more accessible to a broader range of agricultural producers. However, the market faces challenges such as high initial investment costs for advanced genomic equipment and the need for specialized expertise, which can hinder adoption in developing regions. Despite these obstacles, the long-term outlook remains positive, fueled by the undeniable potential of genomics to revolutionize global agriculture.
Regional Analysis: Agrigenomics MarketEurope
Europe represents a highly significant and mature market for agrigenomics, characterized by a strong emphasis on sustainable agriculture and food safety. The region benefits from a robust framework of publicly funded research programs, such as those under the European Union's Horizon Europe initiative, which promote collaborative genomics research across member states. There is a notable focus on developing crops resilient to climate change and on improving the nutritional quality of food. While public skepticism and stringent regulations concerning genetically modified organisms exist, there is growing acceptance and regulatory clarity for newer genomic techniques like gene editing, opening new avenues for market growth. Countries like Germany, France, the Netherlands, and the United Kingdom are key contributors, with strong academic research and a growing number of agri-tech companies applying genomics to enhance organic farming, precision agriculture, and livestock management.
Asia-Pacific
The Asia-Pacific region is the fastest-growing market for agrigenomics, driven by the critical need to ensure food security for its massive population. Governments in major economies such as China and India are heavily investing in national genomics initiatives to boost agricultural productivity. China, in particular, is emerging as a global powerhouse, with state-backed programs focusing on sequencing key crops and livestock to achieve self-sufficiency. The region presents a diverse landscape, with advanced applications in countries like Australia and Japan, alongside rapidly expanding adoption in Southeast Asia. Growth is fueled by the need to address challenges like shrinking arable land, water scarcity, and the impacts of climate change through the development of high-yielding, stress-resistant crop varieties, making it a hotbed for future market expansion.
South America
South America's agrigenomics market is largely driven by its status as a global agricultural powerhouse, particularly in the production of commodities like soybeans, corn, and beef. Countries such as Brazil and Argentina are increasingly adopting genomic technologies to maintain their competitive edge in international markets. The focus is on improving the efficiency and sustainability of large-scale farming operations through advanced breeding techniques for disease resistance and yield optimization in key export crops. While the market is growing, it is often characterized by partnerships with international seed and biotechnology companies, leveraging foreign technology and expertise. The region's growth potential is significant, linked to the continuous expansion of its agricultural frontier and the pressing need to enhance productivity while managing environmental concerns.
Middle East & Africa
The Middle East and Africa region presents a market with high growth potential, though it is currently in a developing stage. The primary drivers are the urgent need to enhance food security in arid and semi-arid environments. In the Middle East, countries with significant financial resources are investing in advanced agricultural technologies, including genomics, for controlled-environment agriculture to overcome water scarcity. In Africa, initiatives are often supported by international aid and development organizations, focusing on genomic applications for staple food crops like cassava, maize, and sorghum to improve resilience to drought and pests. The market is nascent but growing, with potential fueled by demographic pressures and the critical importance of adapting agriculture to challenging climatic conditions.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Agricultural technology companies
Biotechnology and genomics firms
Farmers and agribusinesses
Research institutions and universities
Investors and policy makers
-> Global agrigenomics market was valued at USD 5.01 billion in 2024 and is expected to reach USD 7.92 billion by 2031.
-> Key players include Thermo Fisher Scientific, Illumina, Agilent Technologies, Eurofins, and Zoetis, among others.
-> Key growth drivers include food security concerns, demand for high-yield crops, and technological advancements in sequencing.
-> North America is the largest regional market, accounting for about 50% of global revenue.
-> Emerging trends include gene expression profiling, marker-assisted selection, and climate-resilient crop development.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates